Related Experiment Video
Updated: May 6, 2026
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Transcatheter device closure of patent ductus arteriosus without arterial access--single institution experience
Gaurav Garg1, Anurakti Srivastava, Himanshu Tyagi
1Department of Pediatric Cardiology, Apollo Health City, Jubilee Hills, Hyderabad, India.
Objective:
Retrospective analysis of feasibility, safety and advantages of device closure of patent ductus arteriosus (PDA) using only venous access.
Background:
Arterial access for transcatheter device closure of PDA has been a standard practice, but has inherent complications, especially in infants.
Method:
Records of patients who underwent PDA device closure from 2004 to 2012 were reviewed. Echocardiography was used for patient selection and for assessment of procedural outcome.
Result:
151 out of 179 patients underwent PDA device closure with venous access alone, weighing 2.2-58 kg with half <10 kg and follow up of 6 months-8 years. Fluoroscopic time ranged from 2.2 to 16 min. Immediate closure was achieved in 146 patients. Two patients had new-onset left pulmonary artery turbulence and one had residual flow.
Conclusion:
PDA device closure without arterial access can be accomplished safely and effectively in vast majority of patients including infants.
